Misdiagnosis Statistics in US 2026 | How Common, Conditions & Key Facts

Medical Misdiagnosis in America

Every single day, patients across the United States walk into clinics, emergency rooms, and hospitals trusting that the diagnosis they receive is correct. Far too often, it is not. Medical misdiagnosis — which includes missed diagnoses, delayed diagnoses, and outright wrong diagnoses — is now recognized as the number one cause of serious medical errors in the United States, surpassing surgical mistakes, medication errors, and hospital-acquired infections in terms of overall harm. According to the Agency for Healthcare Research and Quality (AHRQ) and landmark research from Johns Hopkins Medicine, diagnostic errors affect a staggering number of Americans every year, with consequences ranging from delayed treatment to permanent disability and death. Unlike a surgical complication that is visible and immediate, misdiagnosis is often invisible — hidden in a chart, masked by overlapping symptoms, and discovered only when a patient’s condition has already deteriorated beyond the point of easy recovery.

What makes misdiagnosis in the US in 2026 a public health crisis rather than merely a clinical inconvenience is the sheer scale and consistency of the problem. The overall diagnostic error rate across all care settings sits at 10–15% of all medical encounters — a figure repeatedly corroborated by hospital autopsy studies, malpractice claim analyses, and prospective patient safety research over the past two decades. At roughly 1.3 billion healthcare visits annually in the US, that translates to hundreds of millions of potentially flawed diagnoses. While not all lead to serious harm, the ones that do account for 795,000 American deaths or permanent disabilities every single year, according to the most comprehensive national estimate ever conducted, published by Johns Hopkins and Harvard’s Risk Management Foundation in BMJ Quality & Safety (2023, confirmed in 2024 update). That figure has not improved materially heading into 2026 — and with new AHRQ data, NCBI research, and National Practitioner Data Bank (NPDB) reports now available, the picture is sharper and more urgent than ever.

Interesting Facts About Misdiagnosis in the US 2026

MISDIAGNOSIS FAST FACTS — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
 795,000 deaths/disabilities/yr  ████████████████████  annual serious harm toll (Johns Hopkins/BMJ)
 12+ million/yr                  ████████████████████  outpatient diagnostic errors annually
 10–15%                          █████████████████     overall US diagnostic error rate
 11.1% avg error rate            ████████████████      across all "Big Three" diseases (Johns Hopkins)
 1 in 3 malpractice deaths       ████████████          involve misdiagnosis or delayed diagnosis
 5.7% of all ED visits           ████████              have at least one diagnostic error (AHRQ)
 26.6% of malpractice cases      █████████             are diagnostic errors (20-yr claims analysis)
 Women/minorities 20–30% more    ████████████████      likely to be misdiagnosed vs. white men
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: BMJ Quality & Safety 2023/2024; AHRQ Diagnostic Errors in the ED Systematic Review; NCBI Bookshelf StatPearls 2026; Patient Safety Journal January 2025; National Practitioner Data Bank (NPDB) 2025; Cleveland Clinic VSO Analysis 2024

The table above exposes a diagnostic crisis that is both deeply systemic and strikingly predictable. The headline figure — 795,000 Americans killed or permanently disabled by misdiagnosis every year — is not a worst-case projection; it is the most rigorously derived national estimate in the published literature, produced by researchers at Johns Hopkins and Harvard using validated methodology across all care settings. To put that number in perspective, it exceeds the total annual US death toll from stroke (~160,000) and is roughly 16 times the number of Americans who die in car accidents each year. What is especially significant in 2026 is the NPDB data confirming that while the total number of malpractice claims filed in 2025 (9,859) fell slightly from 2024, the average payout per claim rose to $463,000 — a trend driven largely by increasingly large settlements in diagnostic error cases involving death or catastrophic disability.

The second opinion statistic from Cleveland Clinic deserves particular attention. When 67% of patients seeking a second expert opinion receive a changed diagnosis or treatment recommendation, it means that well over half of the people who trusted their original diagnosis enough to seek confirmation were walking around with the wrong one. This is not a marginal problem in edge-case specialties — it spans oncology, cardiology, neurology, and orthopedics. And yet, second opinions remain drastically underutilized in the US healthcare system, in part because patients are not routinely told they should seek them, and in part because insurance coverage for virtual second opinions is inconsistent across payers.

Most Commonly Misdiagnosed Conditions in the US 2026 | The “Big Three”

DIAGNOSTIC ERROR RATE BY CONDITION — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Spinal Abscess            ████████████████████████  56–62% missed
Stroke (dizziness pres.)  ████████████████████      40% missed
Stroke (overall avg)      ██████████████            17% missed
Lung Cancer               ████████████              22.5% missed
Meningitis/Encephalitis   ████████████              ~20% missed
Pulmonary Embolism        ████████████              ~20% missed
Sepsis                    ███████████               ~13% missed
Pneumonia                 ██████████                ~12% missed
Heart Attack (overall)    ███                       1.5% missed
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: Johns Hopkins Armstrong Institute / BMJ Quality & Safety 2023–2024; AHRQ Diagnostic Errors in the Emergency Department Systematic Review (NCBI Bookshelf); NBC News / KFF Health News January 2024

The “Big Three” framework — vascular events, infections, and cancers — was first rigorously defined by Johns Hopkins researchers and has since become the organizing principle of US diagnostic safety policy. Together, these three categories account for 75% of all serious misdiagnosis-related harms across all care settings, and approximately 72% of serious harms specifically in emergency departments. The top five conditions alone — stroke, myocardial infarction, aortic aneurysm/dissection, spinal cord compression, and venous thromboembolism — are responsible for 39% of all serious misdiagnosis-related harms in the ED. Johns Hopkins researchers have calculated that reducing diagnostic errors by just 50% for stroke, sepsis, pneumonia, pulmonary embolism, and lung cancer alone would prevent approximately 150,000 deaths and permanent disabilities per year — a figure that dwarfs the impact of almost any other patient safety intervention currently being pursued in US healthcare.

What the data makes plain is that error rates are not uniform across conditions or presentations. The same disease can carry wildly different miss rates depending on how it presents. Stroke is missed just 4% of the time when a patient arrives with classic motor weakness — but 40% of the time when the presenting symptom is dizziness or vertigo. This is not a failure of individual physician knowledge; it is a failure of diagnostic systems that do not prompt clinicians to consider atypical presentations. The spinal abscess miss rate of 56–62% is particularly alarming — more than half of all spinal abscesses are initially misdiagnosed, typically as benign back pain or musculoskeletal issues, often with catastrophic consequences for spinal function and survival.

Misdiagnosis by Care Setting in the US 2026 | Where Errors Happen

DIAGNOSTIC ERROR RATES BY CARE SETTING — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Ambulatory / Primary Care   ████████████████████  6.3% of encounters (~12M errors/yr)
Emergency Department (ED)   ████████████████      5.7% of visits (~7.4M errors/yr)
Hospital Inpatient           ████████             0.7% of hospitalizations
  (serious harm rate)        ██                   Diagnostic adverse events higher than primary care
ICU (missed/delayed dx)      ████████████████████ 23% of ICU transfers or deaths (JAMA, 2024)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: AHRQ Diagnostic Errors in the Emergency Department Systematic Review (NCBI Bookshelf); JAMA Internal Medicine 2024; JAMA Network Open June 2025; NCBI Bookshelf / StatPearls January 2026

Understanding where misdiagnoses happen in the US healthcare system is as important as understanding how often they occur, because the interventions needed differ sharply by setting. Primary care and ambulatory clinics generate the highest raw volume of diagnostic errors — an estimated 12 million per year — primarily because they see the greatest number of patients and because early-stage disease frequently presents with non-specific symptoms that don’t yet fit a clear pattern. However, the serious harm rate per error in ambulatory settings is generally lower than in hospitals, where sicker patients mean consequences are more immediate and severe.

The emergency department data is particularly striking because of both volume and acuity. With 130 million ED visits annually in the US, even a 5.7% error rate produces 7.4 million diagnostic errors — and with a 0.3% serious harm rate, that translates to roughly 371,000 serious ED misdiagnosis harms annually. The 2024 JAMA Internal Medicine study finding that 23% of patients transferred to an ICU or who died in hospital had a missed or delayed diagnosis — with 17% of those errors leading to temporary or permanent harm — underlines that the inpatient setting, while lower in error frequency, carries devastating consequences when errors do occur. The 2025 JAMA Network Open study of over 302,000 Medicare beneficiaries adds a critical new data point: 3.2% of emergency hospitalizations were preceded by a potential diagnostic error in the ED within the previous nine days, and those hospitalizations were associated with significantly higher 30-day mortality and fewer healthy days at home.

Misdiagnosis Disparities by Gender & Race in the US 2026

MISDIAGNOSIS RISK BY DEMOGRAPHIC GROUP — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
White Men (baseline)         ████████████████████  baseline reference group
Women (overall)              ████████████████████  20–30% higher misdiagnosis risk
Racial/Ethnic minorities     ████████████████████  20–30% higher misdiagnosis risk
Black women (heart attack)   ████████████████████  more likely discharged without dx
Black children (appendicitis)████████████████████  less likely correctly diagnosed
Black patients (depression)  ████████████████████  more likely misdiagnosed as schizophrenia
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: Dr. David Newman-Toker, Johns Hopkins School of Medicine, cited in KFF Health News, NBC News January 2024; Cureus/NCBI August 2025; AHRQ PSNet/Patient Safety Journal January 2025; Undark February 2024

The gender and racial misdiagnosis gap in the US in 2026 is not a statistical artifact — it is a well-documented, peer-reviewed pattern confirmed by multiple independent research teams across different care settings, disease categories, and patient populations. The finding that women and racial/ethnic minorities are 20–30% more likely to be misdiagnosed than white men — stated explicitly by Dr. David Newman-Toker, lead author of the landmark Johns Hopkins BMJ study and director of the Armstrong Institute Center for Diagnostic Excellence — has been replicated broadly and called by Newman-Toker himself “significant and inexcusable.” The causes are multi-layered: implicit bias in clinical decision-making, historical under-representation of women and minorities in clinical trials that define diagnostic criteria, access disparities that delay care, and communication barriers that affect how symptoms are documented and acted upon.

The malpractice payout gender gap identified in the Patient Safety Journal January 2025 analysis of 20 years of closed claims is a particularly sobering data point. Women experience diagnostic errors at higher rates, yet when those errors reach the legal system, the financial settlements awarded are lower than for men with equivalent errors. Researchers note this as an area requiring urgent further investigation — but it is consistent with broader patterns of women’s health complaints being undervalued in both clinical and legal settings. The 2025 Cureus study in NCBI specifically documenting that women with ischemic heart disease are “frequently underdiagnosed and undertreated despite having similar or greater cardiovascular risk” brings the total weight of evidence to a level that can no longer be attributed to coincidence or confounding.

Misdiagnosis Economic & Legal Impact in the US 2026

MISDIAGNOSIS ECONOMIC BURDEN — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Malpractice claims 2025        $4.56 Billion  ████████████████████
Avg payout per claim 2025      $463,000       ████████████████
Claims 2024 total              $5.02 Billion  ████████████████████
Defensive medicine costs       $46 Billion/yr ████████████████████
2nd opinion avg patient saving $8,705         ████████████
High-cost case 2nd opinion sav $100,911       ████████████████████
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: National Practitioner Data Bank (NPDB), US Dept of Health and Human Services; ConsumerShield Medical Malpractice Payouts by State 2026; Patient Safety Journal January 2025 / AHRQ PSNet; Cleveland Clinic / The Clinic VSO Analysis 2024 (BusinessWire); Moore Actuarial Consulting / Medical Economics September 2025

The financial cost of misdiagnosis in the US in 2026 runs into the tens of billions when all dimensions are accounted for. The NPDB data — the most authoritative federal source on malpractice payments — shows that 2025 malpractice payouts reached $4.56 billion across 9,859 claims, with the average settlement climbing to $463,000 — a new high that reflects both the increasing severity of cases reaching settlement and the documented trend of social inflation pushing large-claim payouts upward. The Moore Actuarial Consulting study published in Medical Economics in September 2025 found that inflation added $4 billion to malpractice losses between 2015 and 2024, with $2 million-plus claims now accounting for 3.2% of all payouts — the highest share since the early 2000s. The $46 billion in defensive medicine costs added annually — driven by physicians ordering excess tests precisely to avoid diagnostic error claims — represents one of the most direct economic feedback loops of the misdiagnosis crisis on the broader US healthcare system.

The Cleveland Clinic second opinion data shines a light on a relatively straightforward and dramatically under-deployed solution. At an average saving of $8,705 per patient — and $100,911 per patient in high-cost cases — virtual second opinions not only correct diagnostic errors but do so at a fraction of the cost of downstream treatment for a wrongly diagnosed condition. With 67% of second opinions changing the diagnosis or treatment plan and misdiagnosis accounting for roughly $4.56 billion in annual malpractice payouts, the economic case for systematically integrating second opinions into US healthcare — particularly for the Big Three conditions — is both clinically and financially overwhelming. The continued absence of universal second-opinion coverage in most US insurance plans is, in this context, not just a coverage gap; it is a policy failure with a measurable body count.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE